Taisuke Tsuji

778 total citations
41 papers, 488 citations indexed

About

Taisuke Tsuji is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Taisuke Tsuji has authored 41 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 9 papers in Infectious Diseases. Recurrent topics in Taisuke Tsuji's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers). Taisuke Tsuji is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers). Taisuke Tsuji collaborates with scholars based in Japan and United States. Taisuke Tsuji's co-authors include Noriya Hiraoka, Shinsuke Shiotsu, Shinji Atagi, Akihiro Tamiya, Motohiro Tamiya, Cheng Huang, Motoshige Higashiyama, Masayuki Miyake, Toshihiko Taki and Osamu Doi and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

Taisuke Tsuji

37 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taisuke Tsuji Japan 11 240 227 85 73 67 41 488
Ashita Waterston United Kingdom 11 407 1.7× 51 0.2× 156 1.8× 61 0.8× 66 1.0× 30 675
Rajni Mandal United States 14 190 0.8× 156 0.7× 75 0.9× 53 0.7× 20 0.3× 27 532
Gauri Saini United Kingdom 8 53 0.2× 532 2.3× 146 1.7× 45 0.6× 15 0.2× 20 691
Felipe G. Gercovich Argentina 7 218 0.9× 101 0.4× 83 1.0× 51 0.7× 38 0.6× 29 439
Federica Bosi Italy 11 165 0.7× 164 0.7× 112 1.3× 139 1.9× 12 0.2× 13 505
Haruhi Takagi Japan 7 110 0.5× 58 0.3× 112 1.3× 73 1.0× 10 0.1× 21 322
Tobias Peikert United States 10 97 0.4× 178 0.8× 108 1.3× 74 1.0× 20 0.3× 23 395
Elizabeth Mroczek‐Musulman United States 13 130 0.5× 47 0.2× 199 2.3× 63 0.9× 39 0.6× 41 523
Gino Crivellari Italy 9 91 0.4× 72 0.3× 28 0.3× 43 0.6× 14 0.2× 17 302
Yasuyoshi Sato Japan 11 187 0.8× 102 0.4× 75 0.9× 28 0.4× 5 0.1× 47 380

Countries citing papers authored by Taisuke Tsuji

Since Specialization
Citations

This map shows the geographic impact of Taisuke Tsuji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taisuke Tsuji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taisuke Tsuji more than expected).

Fields of papers citing papers by Taisuke Tsuji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taisuke Tsuji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taisuke Tsuji. The network helps show where Taisuke Tsuji may publish in the future.

Co-authorship network of co-authors of Taisuke Tsuji

This figure shows the co-authorship network connecting the top 25 collaborators of Taisuke Tsuji. A scholar is included among the top collaborators of Taisuke Tsuji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taisuke Tsuji. Taisuke Tsuji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujii, Wataru, Kevin Baßler, Taisuke Tsuji, et al.. (2025). Single-cell transcriptomic analysis of blood and bronchoalveolar lavage fluid in progressive fibrosing interstitial lung diseases. Scientific Reports. 15(1). 31604–31604.
2.
Morimoto, Kenji, Tadaaki Yamada, Toshihide Yokoyama, et al.. (2024). Clinical significance of chronic pulmonary aspergillosis in lung cancer patients undergoing anticancer drug therapy. Thoracic Cancer. 15(26). 1882–1888. 2 indexed citations
3.
4.
Fujii, Wataru, Kevin Baßler, Taisuke Tsuji, et al.. (2024). Immunological characteristics of bronchoalveolar lavage fluid and blood across connective tissue disease-associated interstitial lung diseases. Frontiers in Immunology. 15. 1408880–1408880. 2 indexed citations
5.
Taniguchi, Yoshihiko, Toru Arai, Taisuke Tsuji, et al.. (2024). Cryptogenic organizing pneumonia: clinical outcomes of 60 consecutive cases. Journal of Thoracic Disease. 16(5). 3129–3141. 1 indexed citations
6.
7.
Fujii, Hiroyuki, et al.. (2021). Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin's lymphoma: A case report. Current Problems in Cancer. 45(6). 100739–100739. 9 indexed citations
8.
Tsuji, Taisuke, Yosuke Matsumoto, Shinsuke Shiotsu, et al.. (2020). A case of non–small cell lung cancer with danazol-dependent aplastic anemia induced by pembrolizumab. Current Problems in Cancer. 45(3). 100686–100686. 5 indexed citations
9.
Takaoka, Yuri, et al.. (2020). Single-Center Noninferiority Randomized Trial on the Efficacy and Safety of Low- and High-Dose Rush Oral Milk Immunotherapy for Severe Milk Allergy. International Archives of Allergy and Immunology. 181(9). 699–705. 18 indexed citations
10.
Yoshimura, Akihiro, Tadaaki Yamada, Taisuke Tsuji, et al.. (2019). Prognostic impact of pleural effusion in EGFR‐mutant non‐small cell lung cancer patients without brain metastasis. Thoracic Cancer. 10(3). 557–563. 8 indexed citations
11.
Yoshimura, Akihiro, et al.. (2018). Pulmonary pleomorphic carcinoma with pseudoprogression during nivolumab therapy and the usefulness of tumor markers: A case report. Clinical Case Reports. 6(7). 1338–1341. 10 indexed citations
12.
Tsuyuguchi, Kazunari, Toru Arai, Taisuke Tsuji, et al.. (2018). Change in lung function in never-smokers with nontuberculous mycobacterial lung disease: A retrospective study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 11. 17–21. 5 indexed citations
13.
Naito, Maiko, et al.. (2018). Predictive Factors of Nivolumab-induced Hypothyroidism in Patients with Non-small Cell Lung Cancer. In Vivo. 31(5). 1035–1039. 37 indexed citations
14.
Tsuyuguchi, Kazunari, Shiomi Yoshida, Maiko Naito, et al.. (2018). Mycobacterium abscessus subsp. abscessus Lung Disease: Drug Susceptibility Testing in Sputum Culture Negative Conversion. International Journal of Mycobacteriology. 7(1). 69–69. 7 indexed citations
15.
16.
17.
Asami, Kazuhiro, Masaaki Kawahara, Tomonori Hirashima, et al.. (2014). Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non‐squamous cell non‐small cell lung cancer in Japan. Thoracic Cancer. 5(4). 289–296. 2 indexed citations
18.
Tamiya, Akihiro, Motohiro Tamiya, Takayuki Shiroyama, et al.. (2012). Dose escalation study of carboplatin–pemetrexed followed by maintenance pemetrexed for elderly patients with advanced nonsquamous nonsmall-cell lung cancer. Annals of Oncology. 24(4). 980–985. 22 indexed citations
19.
Hasegawa, Yoshikazu, Tomoya Kawaguchi, Akihito Kubo, et al.. (2011). Ethnic Difference in Hematological Toxicity in Patients with Non-small Cell Lung Cancer Treated with Chemotherapy: A Pooled Analysis on Asian versus Non-Asian in Phase II and III Clinical Trials. Journal of Thoracic Oncology. 6(11). 1881–1888. 44 indexed citations
20.
Tsuji, Taisuke, et al.. (2010). [A case of interstitial pneumonia with autoimmune hemolytic anemia].. PubMed. 48(6). 426–31. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashita Waterston Breakdown of academic impact, for papers by Rajni Mandal Breakdown of academic impact, for papers by Gauri Saini Breakdown of academic impact, for papers by Felipe G. Gercovich Breakdown of academic impact, for papers by Federica Bosi Breakdown of academic impact, for papers by Haruhi Takagi Breakdown of academic impact, for papers by Tobias Peikert Breakdown of academic impact, for papers by Elizabeth Mroczek‐Musulman Breakdown of academic impact, for papers by Gino Crivellari Breakdown of academic impact, for papers by Yasuyoshi Sato
Rankless by CCL
2026